Injectable Egg-Free Influenza Vaccine 2026

The Defense Logistics Agency Troop Support Medical Supply Chain has issued solicitation SPE2DP-25-R-0006 seeking injectable egg-free influenza vaccines for the 2026 season. The procurement requires trivalent or quadrivalent pre-filled syringes suitable for individuals aged 18 and older, with vaccines that must be FDA approved, ACIP recommended, and completely free of eggs and thimerosal. The agency seeks packages containing 10 single-dose pre-filled syringes each, with an estimated annual quantity requirement of 33,750 packages totaling 337,500 individual doses. The contract structure will be a firm-fixed price indefinite quantity arrangement with specific delivery milestones requiring 40% of orders by August 14, 2026, 25% by August 28, 2026, 25% by September 11, 2026, and the final 10% by September 25, 2026. Proposals must be submitted electronically through the DIBBS system with a submission deadline of October 2, 2025 at 3:00 PM EDT.

This opportunity does not include any set-aside designations and is open to all qualified contractors capable of meeting the stringent vaccine manufacturing requirements. The contract establishes quantity parameters with a guaranteed minimum of 75% of the estimated annual amount (approximately 253,125 doses) and a maximum ceiling of 150% of the annual estimate (approximately 506,250 doses). Each dose will include a separate line item for the Federal Excise Tax of $0.75 per dose, which will impact the total contract value depending on actual quantities ordered. The place of performance for delivery will be DLA Distribution Susquehanna PA located in New Cumberland, Pennsylvania. The contract timeline spans the 2026 influenza season with the structured delivery schedule ensuring adequate vaccine availability throughout the critical vaccination period from mid-August through late September 2026.